Logo image of PAX

PATRIA INVESTMENTS LTD-A (PAX) Stock Fundamental Analysis

USA - NASDAQ:PAX - KYG694511059 - Common Stock

14.685 USD
+0.29 (+1.98%)
Last: 10/15/2025, 12:53:45 PM
Fundamental Rating

5

PAX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 237 industry peers in the Capital Markets industry. Both the profitability and the financial health of PAX get a neutral evaluation. Nothing too spectacular is happening here. PAX is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PAX had positive earnings in the past year.
PAX had a positive operating cash flow in the past year.
Each year in the past 5 years PAX has been profitable.
In the past 5 years PAX always reported a positive cash flow from operatings.
PAX Yearly Net Income VS EBIT VS OCF VS FCFPAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 5.40%, PAX is doing good in the industry, outperforming 72.57% of the companies in the same industry.
The Return On Equity of PAX (13.21%) is better than 70.04% of its industry peers.
With an excellent Return On Invested Capital value of 12.65%, PAX belongs to the best of the industry, outperforming 87.76% of the companies in the same industry.
PAX had an Average Return On Invested Capital over the past 3 years of 15.82%. This is significantly above the industry average of 7.58%.
Industry RankSector Rank
ROA 5.4%
ROE 13.21%
ROIC 12.65%
ROA(3y)9.06%
ROA(5y)20.26%
ROE(3y)17.86%
ROE(5y)36.77%
ROIC(3y)15.82%
ROIC(5y)32.16%
PAX Yearly ROA, ROE, ROICPAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

PAX has a Profit Margin (18.47%) which is comparable to the rest of the industry.
PAX's Profit Margin has declined in the last couple of years.
PAX has a Operating Margin of 33.99%. This is in the better half of the industry: PAX outperforms 63.29% of its industry peers.
In the last couple of years the Operating Margin of PAX has declined.
Looking at the Gross Margin, with a value of 51.51%, PAX is in the better half of the industry, outperforming 61.18% of the companies in the same industry.
PAX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 33.99%
PM (TTM) 18.47%
GM 51.51%
OM growth 3Y-15.59%
OM growth 5Y-8.18%
PM growth 3Y-28.26%
PM growth 5Y-16.57%
GM growth 3Y-5.8%
GM growth 5Y-4.11%
PAX Yearly Profit, Operating, Gross MarginsPAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

4

2. Health

2.1 Basic Checks

The number of shares outstanding for PAX has been increased compared to 1 year ago.
Compared to 5 years ago, PAX has more shares outstanding
PAX has a worse debt/assets ratio than last year.
PAX Yearly Shares OutstandingPAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
PAX Yearly Total Debt VS Total AssetsPAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.37 indicates that PAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.37, PAX is in the better half of the industry, outperforming 71.31% of the companies in the same industry.
PAX has a debt to FCF ratio of 1.10. This is a very positive value and a sign of high solvency as it would only need 1.10 years to pay back of all of its debts.
PAX's Debt to FCF ratio of 1.10 is amongst the best of the industry. PAX outperforms 90.30% of its industry peers.
PAX has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
PAX's Debt to Equity ratio of 0.31 is fine compared to the rest of the industry. PAX outperforms 72.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.1
Altman-Z 2.37
ROIC/WACCN/A
WACCN/A
PAX Yearly LT Debt VS Equity VS FCFPAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

PAX has a Current Ratio of 0.97. This is a bad value and indicates that PAX is not financially healthy enough and could expect problems in meeting its short term obligations.
PAX has a Current ratio (0.97) which is in line with its industry peers.
PAX has a Quick Ratio of 0.97. This is a bad value and indicates that PAX is not financially healthy enough and could expect problems in meeting its short term obligations.
PAX's Quick ratio of 0.97 is in line compared to the rest of the industry. PAX outperforms 41.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
PAX Yearly Current Assets VS Current LiabilitesPAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

PAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.27%, which is quite good.
Measured over the past 5 years, PAX shows a small growth in Earnings Per Share. The EPS has been growing by 1.20% on average per year.
Looking at the last year, PAX shows a quite strong growth in Revenue. The Revenue has grown by 13.64% in the last year.
The Revenue has been growing by 24.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.27%
EPS 3Y6.45%
EPS 5Y1.2%
EPS Q2Q%9.09%
Revenue 1Y (TTM)13.64%
Revenue growth 3Y16.7%
Revenue growth 5Y24.89%
Sales Q2Q%10%

3.2 Future

Based on estimates for the next years, PAX will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.27% on average per year.
Based on estimates for the next years, PAX will show a quite strong growth in Revenue. The Revenue will grow by 14.83% on average per year.
EPS Next Y-2.53%
EPS Next 2Y-2.17%
EPS Next 3Y2.19%
EPS Next 5Y9.27%
Revenue Next Year18.32%
Revenue Next 2Y19.1%
Revenue Next 3Y18.25%
Revenue Next 5Y14.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PAX Yearly Revenue VS EstimatesPAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
PAX Yearly EPS VS EstimatesPAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.47, which indicates a very decent valuation of PAX.
66.67% of the companies in the same industry are more expensive than PAX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PAX to the average of the S&P500 Index (27.49), we can say PAX is valued rather cheaply.
The Price/Forward Earnings ratio is 12.37, which indicates a correct valuation of PAX.
The rest of the industry has a similar Price/Forward Earnings ratio as PAX.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, PAX is valued a bit cheaper.
Industry RankSector Rank
PE 11.47
Fwd PE 12.37
PAX Price Earnings VS Forward Price EarningsPAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

PAX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PAX is cheaper than 83.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, PAX is valued a bit cheaper than 68.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.99
EV/EBITDA 13.54
PAX Per share dataPAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

The decent profitability rating of PAX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)9.57
EPS Next 2Y-2.17%
EPS Next 3Y2.19%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.28%, PAX is a good candidate for dividend investing.
PAX's Dividend Yield is comparable with the industry average which is at 8.33.
Compared to an average S&P500 Dividend Yield of 2.43, PAX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

PAX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
PAX Yearly Dividends per sharePAX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

133.26% of the earnings are spent on dividend by PAX. This is not a sustainable payout ratio.
DP133.26%
EPS Next 2Y-2.17%
EPS Next 3Y2.19%
PAX Yearly Income VS Free CF VS DividendPAX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 50M 100M
PAX Dividend Payout.PAX Dividend Payout, showing the Payout Ratio.PAX Dividend Payout.PayoutRetained Earnings

PATRIA INVESTMENTS LTD-A

NASDAQ:PAX (10/15/2025, 12:53:45 PM)

14.685

+0.29 (+1.98%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners72.26%
Inst Owner Change-0.01%
Ins Owners0.34%
Ins Owner ChangeN/A
Market Cap2.34B
Analysts74
Price Target16.32 (11.13%)
Short Float %5.28%
Short Ratio6.5
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend0.88
Dividend Growth(5Y)N/A
DP133.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-15 2025-08-15 (0.15)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.37%
Min EPS beat(2)-8.91%
Max EPS beat(2)65.65%
EPS beat(4)1
Avg EPS beat(4)11.96%
Min EPS beat(4)-8.91%
Max EPS beat(4)65.65%
EPS beat(8)3
Avg EPS beat(8)2.16%
EPS beat(12)5
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)24.05%
Revenue beat(2)1
Avg Revenue beat(2)21.24%
Min Revenue beat(2)-26.12%
Max Revenue beat(2)68.61%
Revenue beat(4)3
Avg Revenue beat(4)12.95%
Min Revenue beat(4)-26.12%
Max Revenue beat(4)68.61%
Revenue beat(8)6
Avg Revenue beat(8)12.75%
Revenue beat(12)8
Avg Revenue beat(12)10.77%
Revenue beat(16)11
Avg Revenue beat(16)26.22%
PT rev (1m)0%
PT rev (3m)7.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.69%
EPS NY rev (1m)0.56%
EPS NY rev (3m)-11.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.25%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)-6.9%
Valuation
Industry RankSector Rank
PE 11.47
Fwd PE 12.37
P/S 6
P/FCF 11.99
P/OCF 11.47
P/B 4.29
P/tB N/A
EV/EBITDA 13.54
EPS(TTM)1.28
EY8.72%
EPS(NY)1.19
Fwd EY8.08%
FCF(TTM)1.22
FCFY8.34%
OCF(TTM)1.28
OCFY8.71%
SpS2.45
BVpS3.42
TBVpS-1.45
PEG (NY)N/A
PEG (5Y)9.57
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 13.21%
ROCE 14.37%
ROIC 12.65%
ROICexc 14.28%
ROICexgc 287.19%
OM 33.99%
PM (TTM) 18.47%
GM 51.51%
FCFM 50.05%
ROA(3y)9.06%
ROA(5y)20.26%
ROE(3y)17.86%
ROE(5y)36.77%
ROIC(3y)15.82%
ROIC(5y)32.16%
ROICexc(3y)24.59%
ROICexc(5y)50.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.97%
ROCE(5y)36.54%
ROICexcg growth 3Y69.86%
ROICexcg growth 5Y42.83%
ROICexc growth 3Y-16.38%
ROICexc growth 5Y-27.63%
OM growth 3Y-15.59%
OM growth 5Y-8.18%
PM growth 3Y-28.26%
PM growth 5Y-16.57%
GM growth 3Y-5.8%
GM growth 5Y-4.11%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.1
Debt/EBITDA 0.98
Cap/Depr 22%
Cap/Sales 2.24%
Interest Coverage 93.68
Cash Conversion 118.33%
Profit Quality 270.95%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 2.37
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)26.69%
Cap/Depr(5y)21.94%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.65%
Profit Quality(3y)132.69%
Profit Quality(5y)113.61%
High Growth Momentum
Growth
EPS 1Y (TTM)13.27%
EPS 3Y6.45%
EPS 5Y1.2%
EPS Q2Q%9.09%
EPS Next Y-2.53%
EPS Next 2Y-2.17%
EPS Next 3Y2.19%
EPS Next 5Y9.27%
Revenue 1Y (TTM)13.64%
Revenue growth 3Y16.7%
Revenue growth 5Y24.89%
Sales Q2Q%10%
Revenue Next Year18.32%
Revenue Next 2Y19.1%
Revenue Next 3Y18.25%
Revenue Next 5Y14.83%
EBIT growth 1Y1.45%
EBIT growth 3Y-1.48%
EBIT growth 5Y14.68%
EBIT Next Year35.2%
EBIT Next 3YN/A
EBIT Next 5Y14.36%
FCF growth 1Y149.79%
FCF growth 3Y9.2%
FCF growth 5Y25.48%
OCF growth 1Y142.79%
OCF growth 3Y10.71%
OCF growth 5Y26.83%